Skip to content

Developing and testing a multicomponent care model for heart disease in India

Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in India - C-QIP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041847
Enrollment
400
Registered
2022-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I00-I99- Diseases of the circulatory system

Interventions

Intervention1: Integrated Comprehensive CVD Management (Intervention Arm): 1) Electronic Health Record-Decision Support Software (EHR-DSS) -Electronic patient health record storage -Management prompts

Sponsors

Public Health Foundation of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age: =18 years, both sex 2.Having physician diagnosis of or on treatment for cardiovascular disease including ischemic heart disease, ischemic stroke, or heart failure regardless of ejection fraction 3.Living within same city/town 4.Consent to participate.

Exclusion criteria

Exclusion criteria: 1.Pregnant women 2.Patients having diseases associated with frequent hospitalization (advanced cancer, end stage renal disease); bedridden or debilitating conditions and life expectancy

Design outcomes

Primary

MeasureTime frame
1. Acceptibilty 2. Adoption 3. Appropriateness 4. Cost 5. Feasibilty 6. FidelityTimepoint: maximum: 24 months, average: 18 months

Secondary

MeasureTime frame
Other Pre-specified Outcome Measure: Between group differences in: 1. Mean changes in blood pressure at trial end 2. Mean changes in LDL cholesterol at trial end 3. Mean change in health-related quality of life 4. Incremental cost of care 5. Adherence to recommended lifestyle habits: smoking cessation, diet, physical activity, and mental healthTimepoint: maximum: 24 months, average: 18 months;Prescription rate of guideline directed medical therapy (GDMT) by providers Patients adherence rate to GDMTTimepoint: maximum: 24 months, average: 18 months

Countries

India

Contacts

Public ContactKavita Singh

Public Health Foundation of India (PHFI)

kavita.singh@phfi.org

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 6, 2026